Ilkka Kantola

White-coat and masked hypertension as risk factors for progression to sustained hypertension: the Finn-Home study (2016)

Journal of Hypertension

Siven SSE, Niiranen TJ, Kantola IM, Jula AM

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Hypertensio (2016)

Kantola I, Niiranen T

(Artikkeli ammatillisessa kokoomateoksessa (D2))

High blood pressure and its variation and the use of beta blocking agents and statins decrease quality of life in drug-treated hypertensive patients (2015)

Journal of Hypertension

Kantola I1, Merikari M, Tervo J, Koskio L, Haijanen J, Hermansson H, Kantola T, Mäkelä P, Rehunen S, Varis J

(Muu (O2))

Factors modifying the effect of blood pressure on erectile function (2015)

Journal of Hypertension

Korhonen PE, Ettala O, Kautiainen H, Kantola I

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document (2015)

Orphanet Journal of Rare Diseases

Biegstraaten M, Arngrímsson R, Barbey F, Boks L, Cecchi F, Deegan PB, Feldt-Rasmussen U, Geberhiwot T, Germain DP, Hendriksz C, Hughes DA, Kantola I Karabul N, Lavery C, Linthorst GE, Mehta A, van de Mheen E, Oliveira JP, Parini R, Ramaswami U, Rudnicki M, Serra A, Sommer C, Sunder-Plassmann G, Svarstad E, Sweeb A, Terryn W, Tylki-Szymanska A, Tøndel C, Vujkovac B, Weidemann F, Wijburg FA, Woolfson P, Hollak CE

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

A male Fabry disease patient treated with intravenous thrombolysis for acute ischemic stroke (2015)

Journal of Clinical Neuroscience

Saarinen JT, Sillanpaa N, Kantola I

(Kirjoitus tai data-artikkeli tieteellisessä aikakauslehdessä (B1))

Evaluation of the efficacy and safety of three dosing regimens of agalsidase alfa enzyme replacement therapy in adults with Fabry disease (2015)

Drug Design, Development and Therapy

Goláň L, Goker-Alpan O, Holida M, Kantola I, Klopotowski M, Kuusisto J, Linhart A, Musial J, Nicholls K, Gonzalez-Rodriguez D, Sharma R, Vujkovac B, Chang P, Wijatyk A

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Individual patient data meta-analysis of self-monitoring of blood pressure (BP-SMART): a protocol (2015)

BMJ Open

Tucker KL, Sheppard JP, Stevens R, Bosworth HB, Bove A, Bray EP, Godwin M, Green B, Hebert P, Hobbs FDR, Kantola I, Kerry S, Magid DJ, Mant J, Margolis KL, McKinstry B, Omboni S, Ogedegbe O, Parati G, Qamar N, Varis J, Verberk W, Wakefield BJ, McManus RJ

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

High prevalence of chronic kidney disease in Finnish patients with type 2 diabetes treated in primary care (2015)

Primary Care Diabetes

Metsarinne K, Broijersen A, Kantola I, Niskanen L, Rissanen A, Appelroth T, Pontynen N, Poussa T, Koivisto V, Virkamaki A; for the STONE (STages of NEphropathy in type 2 diabetes) study investigators

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

ECG left ventricular hypertrophy is a stronger risk factor for incident cardiovascular events in women than in men in the general population (2015)

Journal of Hypertension

Porthan K, Niiranen TJ, Varis J, Kantola I, Karanko H, Kähönen M, Nieminen MS, Salomaa V, Huikuri HV, Jula AM

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Contact

Links

Areas of expertise

Publications

Sort by:

White-coat and masked hypertension as risk factors for progression to sustained hypertension: the Finn-Home study (2016)

Hypertensio (2016)

High blood pressure and its variation and the use of beta blocking agents and statins decrease quality of life in drug-treated hypertensive patients (2015)

Factors modifying the effect of blood pressure on erectile function (2015)

Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document (2015)

A male Fabry disease patient treated with intravenous thrombolysis for acute ischemic stroke (2015)

Evaluation of the efficacy and safety of three dosing regimens of agalsidase alfa enzyme replacement therapy in adults with Fabry disease (2015)

Individual patient data meta-analysis of self-monitoring of blood pressure (BP-SMART): a protocol (2015)

High prevalence of chronic kidney disease in Finnish patients with type 2 diabetes treated in primary care (2015)

ECG left ventricular hypertrophy is a stronger risk factor for incident cardiovascular events in women than in men in the general population (2015)